Latest Industry Press Releases More...

We bring you the latest pharmaceutical press releases in our pharmaceutical Industry Press Releases section to help our clients gain great exposure on industry happenings. Know about mergers, deals, technology release, and other information first hand from press conferences of industry leaders with our Global pharmaceuticals Industry Press Releases.

Eurofins Scientific, a global leader in bioanalytical testing, announces that it has acquired Spectro Analytical Labs Ltd. (“Spectro”), a leading environment, analytical product testing and inspection company in India. The company has over 22 years of experience in quality testing and inspection-related services, and owns accreditations from the National Accreditation…

Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today announced the commencement of patient dosing in its Phase 2 clinical trial designed in accordance with the requirements of…

LabCorp a leading global life sciences company, today announced the U.S. availability of the PD-L1 IHC 28-8 pharmDx assay as a complementary diagnostic for two newly approved indications in connection with the use of Bristol-Myers Squibb’s OPDIVO® (nivolumab) to treat patients with metastatic urothelial carcinoma, also referred to as bladder…

Sangamo Therapeutics, Inc. announced treatment of the first patient in the Phase 1/2 clinical trial ("the CHAMPIONS study") evaluating SB-913, an investigational in vivo genome editing therapy for people with mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome. "For the first time, a patient has received a therapy…

Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K.. The acquisition strengthens and expands Quotient’s formulation and manufacturing services footprint in the U.K., and further supports the growth of Quotient’s Translational Pharmaceutics® platform, following the acquisitions…

Certara®, the global leader in model-informed drug development and regulatory science, today announced that the US Food and Drug Administration (FDA) has greatly expanded its use of Certara’s PBPK Simcyp® Population-based Simulator and its Pediatric and Cardiac Safety Simulators. Under the new agreement, FDA has almost tripled its number of…

Wednesday, Nov 15, 2017

As we are approaching our highly anticipated 2nd Annual Genome Editing USA Congress we wanted to share with you the latest updates regarding the conference programme. You will network and learn valuable insights into this rapidly advancing industry; discuss the key areas that are shaping the market including today, including:…

Wednesday, Nov 15, 2017

Join us at the forefront of industry innovation at the 5th Annual Peptides Congress, 16-17 April 2018, London to shape the future of industry discussion. With over 700 peptides in clinical trials and an increasing industry focus on biologics, now more than ever is the time to focus on this…

Wednesday, Nov 15, 2017

Join over 300 leading experts for Europe’s most prestigious drug discovery congress at the 19th Annual Drug Discovery Summit, 7-8 June 2018, Berlin, Germany. Bringing you the latest research in drug discovery innovations and strategies, discovery enabling technologies and novel drug targets; our industry renowned speakers will give you the…

Today, the U.S. Patent & Trademark Office (PTO) granted Argentum Pharmaceuticals LLC's petition for inter partes review (IPR) against all patent claims in the first patent listed in the Food & Drug Administration's Orange Book as covering Valeant Pharmaceuticals' JUBLIA® (efinaconazole topical solution 10%). Argentum is challenging all claims of…

loader